发明名称 Individual 5-fluorouracile dose optimization in FOLFOX treatment
摘要 <p>The present invention belongs to the field of improved personalized medicine. More precisely, the present invention relates to a method for progressively optimizing the 5 -FU dose administered by continuous infusion in patients treated by a FOLFOX regimen or a similar regimen, based on the 5 -FU plasmatic concentration measured during the previous 5 -FU continuous infusion and on a herein described decision algorithm. The present invention also relates to a method for treating a cancer patient in which the 5 -FU dose administered in continuous infusion in each FOLFOX or similar treatment cycle is optimized using the decision algorithm according to the invention.</p>
申请公布号 AU2008362108(B2) 申请公布日期 2015.09.03
申请号 AU20080362108 申请日期 2008.09.26
申请人 UNIVERSITE D'ANGERS;INSTITUT DE CANCEROLOGIE DE L'OUEST 发明人 GAMELIN, ERICK;BOISDRON-CELLE, MICHELE;MOREL, ALAIN
分类号 G01N33/574;G01N33/94 主分类号 G01N33/574
代理机构 代理人
主权项
地址